News LEO Pharma teams up with Wearifi for dermatology research we... LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.